Publications
Found 2 results
Filters: Author is L.Z. Chen [Clear All Filters]
, “Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up”, vol. 14, pp. 10672-10681, 2015.
, “Association of MHC class-III gene polymorphisms with ER-positive breast cancer in Chinese Han population”, vol. 11, pp. 4299-4306, 2012.
Anderson WF, Chu KC, Chatterjee N, Brawley O, et al. (2001). Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J. Clin. Oncol. 19: 18-27.
PMid:11134191
Baccar HA, Yacoubi LB, Troudi W, Hmida S, et al. (2006). HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia? Pathol. Oncol. Res. 12: 79-81.
http://dx.doi.org/10.1007/BF02893448
Bhutia SK, Mallick SK and Maiti TK (2010). Tumour escape mechanisms and their therapeutic implications in combination tumour therapy. Cell Biol. Int. 34: 553-563.
http://dx.doi.org/10.1042/CBI20090206
PMid:20384587
Cantú de León D, Perez-Montiel D, Villavicencio V, Garcia CA, et al. (2009). High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer 9: 48.
http://dx.doi.org/10.1186/1471-2407-9-48
PMid:19196481 PMCid:2653544
de Jong MM, Nolte IM, de Vries EG, Schaapveld M, et al. (2003). The HLA class III subregion is responsible for an increased breast cancer risk. Hum. Mol. Genet. 12: 2311-2319.
http://dx.doi.org/10.1093/hmg/ddg245
PMid:12915440
Dunn GP, Bruce AT, Ikeda H, Old LJ, et al. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3: 991-998.
http://dx.doi.org/10.1038/ni1102-991
PMid:12407406
Dunnwald LK, Rossing MA and Li CI (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 9: R6.
http://dx.doi.org/10.1186/bcr1639
PMid:17239243 PMCid:1851385
Ghaderi A, Talei A, Gharesi-Fard B, Farjadian SH, et al. (2001). HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathol. Oncol. Res. 7: 39-41.
http://dx.doi.org/10.1007/BF03032603
PMid:11349219
Gruen JR and Weissman SM (2001). Human MHC class III and IV genes and disease associations. Front Biosci. 6: D960-D972.
http://dx.doi.org/10.2741/Gruen
PMid:11487469
Gun FD, Ozturk OG, Polat A and Polat G (2012). HLA class-II allele frequencies in Turkish breast cancer patients. Med. Oncol. 29: 466-471.
http://dx.doi.org/10.1007/s12032-011-9873-4
PMid:21373933
Hashimoto M, Nakamura N, Obayashi H, Kimura F, et al. (1999). Genetic contribution of the BAT2 gene microsatellite polymorphism to the age-at-onset of insulin-dependent diabetes mellitus. Hum. Genet. 105: 197-199.
http://dx.doi.org/10.1007/s004390051089
PMid:10987645
Iris FJ, Bougueleret L, Prieur S, Caterina D, et al. (1993). Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nat. Genet. 3: 137-145.
http://dx.doi.org/10.1038/ng0293-137
PMid:8499947
Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90.
http://dx.doi.org/10.3322/caac.20107
PMid:21296855
Lavado R, Benavides M, Villar E, Ales I, et al. (2005). The HLA-B7 allele confers susceptibility to breast cancer in Spanish women. Immunol. Lett. 101: 223-225.
http://dx.doi.org/10.1016/j.imlet.2005.03.006
PMid:16188571
Linos E, Spanos D, Rosner BA, Linos K, et al. (2008). Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J. Natl. Cancer Inst. 100: 1352-1360.
http://dx.doi.org/10.1093/jnci/djn305
PMid:18812552 PMCid:2556703
Mahmoodi M, Nahvi H, Mahmoudi M, Kasaian A, et al. (2012). HLA-DRB1, -DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer. Pathol. Oncol. Res. 18: 49-55.
http://dx.doi.org/10.1007/s12253-011-9415-6
PMid:21720852
Mestiri S, Bouaouina N, Ahmed SB, Khedhaier A, et al. (2001). Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 91: 672-678.
http://dx.doi.org/10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J
Milner CM and Campbell RD (2001). Genetic organization of the human MHC class III region. Front Biosci. 6: D914-D926.
http://dx.doi.org/10.2741/Milner
PMid:11487476
Shiina T, Inoko H and Kulski JK (2004). An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64: 631-649.
http://dx.doi.org/10.1111/j.1399-0039.2004.00327.x
PMid:15546336
Singal DP, Li J and Zhu Y (2000). HLA class III region and susceptibility to rheumatoid arthritis. Clin. Exp. Rheumatol. 18: 485-491.
PMid:10949724
Spies T, Blanck G, Bresnahan M, Sands J, et al. (1989). A new cluster of genes within the human major histocompatibility complex. Science 243: 214-217.
http://dx.doi.org/10.1126/science.2911734
PMid:2911734
Xie T, Rowen L, Aguado B, Ahearn ME, et al. (2003). Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res. 13: 2621-2636.
http://dx.doi.org/10.1101/gr.1736803
PMid:14656967 PMCid:403804
Yu CY (1998). Molecular genetics of the human MHC complement gene cluster. Exp. Clin. Immunogenet. 15: 213-230.
http://dx.doi.org/10.1159/000019075
PMid:10072631
Ziegler RG, Anderson WF and Gail MH (2008). Increasing breast cancer incidence in China: the numbers add up. J. Natl. Cancer Inst. 100: 1339-1341.
http://dx.doi.org/10.1093/jnci/djn330
PMid:18812546